Prevalence of rifampicin-resistant Mycobacterium tuberculosis among human-immunodeficiency-virus-seropositive patients and their treatment outcomes
Multidrug resistant (MDR) and extensively drug resistant tuberculosis (TB) are a threat to the TB control programs in developing countries, and the situation is worsened by the human immunodeficiency virus (HIV) pandemic. This study was performed to correlate treatment outcome with the resistance pa...
Saved in:
Main Authors: | C.K. Vidyaraj (Author), A. Chitra (Author), S. Smita (Author), M. Muthuraj (Author), S. Govindarajan (Author), B. Usharani (Author), S. Anbazhagi (Author) |
---|---|
Format: | Book |
Published: |
Springer,
2019-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk Factors and Treatment Outcome Analysis Associated with Second-Line Drug-Resistant Tuberculosis
by: Muralidhar Aaina, et al.
Published: (2021) -
Mutations inside rifampicin-resistance determining region of rpoB gene associated with rifampicin-resistance in Mycobacterium tuberculosis
by: Myo T. Zaw, et al.
Published: (2018) -
Evaluation of the genexpert Mycobacterium tuberculosis/Rifampicin assay for early detection of extrapulmonary tuberculosis and rifampicin resistance in aligarh region of Northern India
by: M D Ahsan Imam, et al.
Published: (2023) -
Evaluation of phage assay for rapid phenotypic detection of rifampicin resistance in <it>Mycobacterium tuberculosis</it>
by: Montoro Ernesto, et al.
Published: (2006) -
Molecular analysis of rpoB gene mutations in rifampicin resistant Mycobacterium tuberculosis isolates by multiple allele specific polymerase chain reaction in Puducherry, South India
by: Ravibalan Thirumurugan, et al.
Published: (2015)